2005
Atrial fibrillation: How to approach rate control
Rosenfeld LE. Atrial fibrillation: How to approach rate control. Current Cardiology Reports 2005, 7: 391-397. PMID: 16105496, DOI: 10.1007/s11886-005-0094-3.Commentaries, Editorials and LettersConceptsPrevention of tachycardiaRhythm control strategyMinority of patientsCalcium channel blockersReduction of symptomsUse of therapiesEvidence-based definitionConsiderable clinical importanceNodal ablationAtrial fibrillationSerial assessmentNovel therapiesChannel blockersΒ-blockersHeart rateClinical importanceOptimal managementTherapySymptomsRate controlTachycardiaPatientsCardiomyopathyFibrillationBlockers
1998
Inappropriate Sensing of Atrial Stimuli in Patients with Third‐Generation Defibrillators and DDD Pacemakers
LAMPERT R, McPHERSON C, LEWIS R, BATSFORD W, ROSENFELD L. Inappropriate Sensing of Atrial Stimuli in Patients with Third‐Generation Defibrillators and DDD Pacemakers. Pacing And Clinical Electrophysiology 1998, 21: 1225-1229. PMID: 9633064, DOI: 10.1111/j.1540-8159.1998.tb00181.x.Peer-Reviewed Original ResearchConceptsAtrial stimulusAtrial sensingVDD modeDDD pacemakerActive fixation leadsThird generation defibrillatorTV-ICDHeart blockInappropriate therapyTransvenous ICDVentricular stimuliIntraoperative testingPatientsAtrial locationCurrent ICDICDAtrial positionICD sensingPacemakerStimuliTherapyVVIDefibrillator
1996
Initial Single‐Center Experience with an Advanced Third‐Generation Investigational Defibrillator
LAMPERT R, ROSENFELD L, McPHERSON C, LEWIS R, VANZETTA A, BATSFORD W. Initial Single‐Center Experience with an Advanced Third‐Generation Investigational Defibrillator. Pacing And Clinical Electrophysiology 1996, 19: 2072-2082. PMID: 8994946, DOI: 10.1111/j.1540-8159.1996.tb03281.x.Peer-Reviewed Original ResearchConceptsImplantable cardioverter defibrillatorDefibrillation thresholdInitial single-center experienceYale-New Haven HospitalShocking electrodesSingle-center experienceLow-energy biphasic shocksBiphasic defibrillation thresholdLower defibrillation thresholdInappropriate therapyVentricular arrhythmiasVT zoneNonthoracotomy implantationCardioverter defibrillatorEffective treatmentVF zoneAV dissociationTransvenous systemsPatientsAvailable electrogramsNoninvasive electrophysiologyRR intervalsEPS resultsTherapyBiphasic shocks
1992
Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate
Hijazi Z, Rosenfeld L, Copel J, Kleinman C. Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate. Pediatric Cardiology 1992, 13: 227-229. PMID: 1518742, DOI: 10.1007/bf00838781.Peer-Reviewed Case Reports and Technical Notes
1988
Device Therapy of Ventricular Tachyarrhythmias
Rosenfeld L. Device Therapy of Ventricular Tachyarrhythmias. Cardiology Clinics 1988, 6: 437-448. PMID: 3073009, DOI: 10.1016/s0733-8651(18)30487-9.Peer-Reviewed Original ResearchConceptsDevice therapyLife-threatening ventricular arrhythmiasConcomitant antiarrhythmic therapyMajority of patientsManagement of patientsAntitachycardia devicesAntiarrhythmic therapyPatient selectionVentricular arrhythmiasVentricular tachyarrhythmiasVentricular fibrillationAntitachycardia pacemakerDefibrillation capabilitySuch drugsTherapyPatients
1985
Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing
McPherson C, Rosenfeld L, Batsford W. Day-to-day reproducibility of responses to right ventricular programmed electrical stimulation: Implications for serial drug testing. The American Journal Of Cardiology 1985, 55: 689-695. PMID: 3976510, DOI: 10.1016/0002-9149(85)90138-9.Peer-Reviewed Original ResearchConceptsVentricular tachycardiaVT inductionElectrical stimulationInduction of VTAntiarrhythmic drug therapySerial drug testingSecond control studySuch patientsPatient groupDrug therapyDay reproducibilityPatientsMore PEControl studyElectrical stimuliDrug testingStimulation modeBaseline stateStimulationTherapyInductionDaysFirst studyResponseTachycardia